Published in Methods Enzymol on January 01, 1981
The human prothymosin alpha gene is polymorphic and induced upon growth stimulation: evidence using a cloned cDNA. Proc Natl Acad Sci U S A (1986) 1.43
Ascorbate stimulation of PAT cells causes an increase in transcription rates and a decrease in degradation rates of procollagen mRNA. Nucleic Acids Res (1984) 1.21
Mouse sn-glycerol-3-phosphate dehydrogenase: molecular cloning and genetic mapping of a cDNA sequence. Proc Natl Acad Sci U S A (1983) 1.09
Role of procollagen mRNA levels in controlling the rate of procollagen synthesis. Mol Cell Biol (1983) 1.03
Emv-13 (Akv-3): a noninducible endogenous ecotropic provirus of AKR/J mice. J Virol (1983) 0.97
Molecular cloning of a prolactin-related mRNA expressed in bovine placenta. Proc Natl Acad Sci U S A (1987) 0.86
Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev (2000) 9.36
Yeast Gcn5 functions in two multisubunit complexes to acetylate nucleosomal histones: characterization of an Ada complex and the SAGA (Spt/Ada) complex. Genes Dev (1997) 8.35
Expression of human immune interferon cDNA in E. coli and monkey cells. Nature (1982) 6.55
Inhibition of intractable nucleases with ribonucleoside--vanadyl complexes: isolation of messenger ribonucleic acid from resting lymphocytes. Biochemistry (1979) 6.00
The TAF(II)250 subunit of TFIID has histone acetyltransferase activity. Cell (1996) 5.20
p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol (1999) 4.88
BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene (1998) 4.88
Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol Cell (2001) 4.73
Phosphorylation of serine 10 in histone H3 is functionally linked in vitro and in vivo to Gcn5-mediated acetylation at lysine 14. Mol Cell (2000) 4.05
Functional organization of the yeast SAGA complex: distinct components involved in structural integrity, nucleosome acetylation, and TATA-binding protein interaction. Mol Cell Biol (1999) 3.90
First-strand cDNA synthesis primed with oligo(dT). Methods Enzymol (1987) 3.06
Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res (1981) 3.00
Functional similarity and physical association between GCN5 and ADA2: putative transcriptional adaptors. EMBO J (1994) 3.00
Critical residues for histone acetylation by Gcn5, functioning in Ada and SAGA complexes, are also required for transcriptional function in vivo. Genes Dev (1998) 2.76
Snf1--a histone kinase that works in concert with the histone acetyltransferase Gcn5 to regulate transcription. Science (2001) 2.58
Histone acetyltransferase activity and interaction with ADA2 are critical for GCN5 function in vivo. EMBO J (1997) 2.58
Structure of Tetrahymena GCN5 bound to coenzyme A and a histone H3 peptide. Nature (1999) 2.50
Preparation of cDNA and the generation of cDNA libraries: overview. Methods Enzymol (1987) 2.40
Characterization of physical interactions of the putative transcriptional adaptor, ADA2, with acidic activation domains and TATA-binding protein. J Biol Chem (1995) 2.37
Identification of human proteins functionally conserved with the yeast putative adaptors ADA2 and GCN5. Mol Cell Biol (1996) 2.30
The SAGA unfolds: convergence of transcription regulators in chromatin-modifying complexes. Trends Cell Biol (1998) 2.28
Catalytic mechanism and function of invariant glutamic acid 173 from the histone acetyltransferase GCN5 transcriptional coactivator. J Biol Chem (1999) 2.13
A randomized trial of radical radiotherapy for the management of pT1G3 NXM0 transitional cell carcinoma of the bladder. J Urol (2007) 2.12
Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc Natl Acad Sci U S A (1998) 2.11
Structural and functional analysis of yeast putative adaptors. Evidence for an adaptor complex in vivo. J Biol Chem (1996) 2.01
Inhibition of TATA-binding protein function by SAGA subunits Spt3 and Spt8 at Gcn4-activated promoters. Mol Cell Biol (2000) 2.00
The ADA complex is a distinct histone acetyltransferase complex in Saccharomyces cerevisiae. Mol Cell Biol (1999) 2.00
Crystal structure and mechanism of histone acetylation of the yeast GCN5 transcriptional coactivator. Proc Natl Acad Sci U S A (1999) 1.99
New lamps for old. Proc R Soc Med (1973) 1.93
Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest (1983) 1.91
Global analysis of transcription kinetics during competence development in Streptococcus pneumoniae using high density DNA arrays. Mol Microbiol (2000) 1.89
Patients' tolerance of transrectal ultrasound-guided prostatic biopsy: an audit of 104 cases. BJU Int (1999) 1.86
Gene expression during reactivation of herpes simplex virus type 1 from latency in the peripheral nervous system is different from that during lytic infection of tissue cultures. J Virol (1997) 1.86
Histone acetyltransferase activity is conserved between yeast and human GCN5 and is required for complementation of growth and transcriptional activation. Mol Cell Biol (1997) 1.85
During lytic infection herpes simplex virus type 1 is associated with histones bearing modifications that correlate with active transcription. J Virol (2004) 1.84
Crystal structure of yeast Esa1 suggests a unified mechanism for catalysis and substrate binding by histone acetyltransferases. Mol Cell (2000) 1.80
Spectrin deficient inherited hemolytic anemias in the mouse: characterization by spectrin synthesis and mRNA activity in reticulocytes. Cell (1984) 1.77
Differential activation of RNA polymerase III-transcribed genes by the polyomavirus enhancer and the adenovirus E1A gene products. Nucleic Acids Res (1985) 1.72
Absence of Gcn5 HAT activity defines a novel state in the opening of chromatin at the PHO5 promoter in yeast. Mol Cell (1998) 1.71
Two tandem and independent sub-activation domains in the amino terminus of p53 require the adaptor complex for activity. Oncogene (1997) 1.70
CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein. Cancer Res (1997) 1.70
Ribonuclease H activities associated with viral reverse transcriptases are endonucleases. Proc Natl Acad Sci U S A (1989) 1.67
Cellular pharmacology of 2',3'-dideoxy-2',3'-didehydrothymidine, a nucleoside analog active against human immunodeficiency virus. Antimicrob Agents Chemother (1989) 1.66
Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. Mol Pharmacol (1992) 1.65
Occupational bladder tumour cases identified during ten years' interviewing of patients. Br J Urol (1976) 1.63
The long-term follow-up of surgically treated vesicoureteric reflux. Br J Urol (1978) 1.61
Characterization of infectivity of knob-modified adenoviral vectors in glioma. Cancer Biol Ther (2008) 1.61
Radiotherapy for patients with tumours of the testicle. Br J Urol (1971) 1.60
Mutations in a NIMA-related kinase gene, Nek1, cause pleiotropic effects including a progressive polycystic kidney disease in mice. Proc Natl Acad Sci U S A (2000) 1.57
T.N.M. classification for urological tumours (U.I.C.C.) - 1974. Br J Urol (1975) 1.57
A conserved motif present in a class of helix-loop-helix proteins activates transcription by direct recruitment of the SAGA complex. Mol Cell (1999) 1.55
Large- and small-scale phenol extractions. Methods Enzymol (1987) 1.55
Gene expression in chemically transformed mouse embryo cells: selective enhancement of the expression of C type RNA tumor virus genes. Cell (1977) 1.52
Histone acetyltransferase complexes. Semin Cell Dev Biol (1999) 1.52
Repression of GCN5 histone acetyltransferase activity via bromodomain-mediated binding and phosphorylation by the Ku-DNA-dependent protein kinase complex. Mol Cell Biol (1998) 1.50
A haematuria diagnostic service. Br Med J (1977) 1.50
Nucleotides in the polyomavirus enhancer that control viral transcription and DNA replication. Mol Cell Biol (1987) 1.48
Bcl-2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapy. BJU Int (2000) 1.47
Targeted eradication of ovarian cancer mediated by intracellular expression of anti-erbB-2 single-chain antibody. Gynecol Oncol (1995) 1.47
Cloning of Drosophila GCN5: conserved features among metazoan GCN5 family members. Nucleic Acids Res (1998) 1.47
The human prothymosin alpha gene is polymorphic and induced upon growth stimulation: evidence using a cloned cDNA. Proc Natl Acad Sci U S A (1986) 1.43
Molecular hybridization of immobilized nucleic acids: theoretical concepts and practical considerations. Methods Enzymol (1987) 1.43
Crystal structure of the histone acetyltransferase domain of the human PCAF transcriptional regulator bound to coenzyme A. EMBO J (1999) 1.39
1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl] cytosine, an intracellular prodrug for (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine with improved therapeutic index in vivo. Antimicrob Agents Chemother (1994) 1.39
The management of deeply infiltrating (T3) bladder carcinoma: controlled trial of radical radiotherapy versus preoperative radiotherapy and radical cystectomy (first report). Br J Urol (1976) 1.38
Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group Trial. J Pediatr Hematol Oncol (2001) 1.37
Precipitation of nucleic acids. Methods Enzymol (1987) 1.36
Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy. Br J Urol (1982) 1.33
Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (1995) 1.32
In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals. Clin Exp Metastasis (1995) 1.32
Purkinje cell degeneration associated with erythroid ankyrin deficiency in nb/nb mice. J Cell Biol (1991) 1.32
Isolation of cytoplasmic RNA: ribonucleoside-vanadyl complexes. Methods Enzymol (1987) 1.30
Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum Mol Genet (1995) 1.30
1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol Biomarkers Prev (1997) 1.29
Immunohistochemistry in the evaluation of neovascularization in tumor xenografts. Biotech Histochem (2008) 1.27
Small, membrane-bound, alternatively spliced forms of ankyrin 1 associated with the sarcoplasmic reticulum of mammalian skeletal muscle. J Cell Biol (1997) 1.27
Ankyrin and the hemolytic anemia mutation, nb, map to mouse chromosome 8: presence of the nb allele is associated with a truncated erythrocyte ankyrin. Proc Natl Acad Sci U S A (1990) 1.26
Osteosarcoma in a patient with McCune-Albright syndrome and Mazabraud's syndrome. Skeletal Radiol (1999) 1.25
Breast cancer metastasis to bone: evaluation of bioluminescent imaging and microSPECT/CT for detecting bone metastasis in immunodeficient mice. Clin Exp Metastasis (2007) 1.24
In vitro and in vivo disposition and metabolism of 3'-deoxy-2',3'-didehydrothymidine. Antimicrob Agents Chemother (1993) 1.23
Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus. J Virol (1998) 1.22
Reverse transcriptase and its associated ribonuclease H: interplay of two enzyme activities controls the yield of single-stranded complementary deoxyribonucleic acid. Biochemistry (1983) 1.22
Sarcomas of bone complicating osteitis deformans (Paget's disease): fifty years' experience. Am J Surg Pathol (1981) 1.20
Synthesis and in vitro evaluation of a phosphonate prodrug: bis(pivaloyloxymethyl) 9-(2-phosphonylmethoxyethyl)adenine. Antiviral Res (1992) 1.20
High-frequency fusion of Streptomyces parvulus or Streptomyces antibioticus protoplasts induced by polyethylene glycol. J Bacteriol (1979) 1.19
The porphyria, plumbism, pottery puzzle. JAMA (1982) 1.18
Evaluation of infrequent dosing regimens with (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine (S-HPMPC) on simian varicella infection in monkeys. Antiviral Res (1991) 1.17
Use of anti-basement membrane antibodies to distinguish blood vessel capillaries from lymphatic capillaries. Am J Surg Pathol (1983) 1.17
Laminin promotes rabbit neutrophil motility and attachment. J Clin Invest (1986) 1.17
Pharmacokinetics of cidofovir in monkeys. Evidence for a prolonged elimination phase representing phosphorylated drug. Drug Metab Dispos (1996) 1.17
The evolution of the cystoscope. Nurs Mirror Midwives J (1975) 1.17
Biochemical pharmacology of acyclic nucleotide analogues. Ann N Y Acad Sci (1990) 1.17
1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine. A highly potent and selective anti-HIV agent. J Med Chem (1989) 1.17
Structure and function of bromodomains in chromatin-regulating complexes. Gene (2001) 1.15
Ureteric diversion using a conduit: a simplified technique. Br J Urol (1966) 1.15
A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial. Clin Cancer Res (2000) 1.14
Stages of neoplastic transformation of human breast tissue as monitored by dissolution of basement membrane components. An immunoperoxidase study. Invasion Metastasis (1981) 1.14